Nov 16, 2023 / 09:30AM GMT
Akash Tewari - Jefferies LLC, Research Division - Equity Analyst
Last day, exciting stuff. London Healthcare Conference. My name is Akash Tewari. Can you even pronounce my name? I'm a pharma and biotech analyst here at Jefferies. I have the pleasure of hosting Tim Power, Head of Bristol IR, for a nice one-on-one fireside chat discussion today. Tim, let me hand it to you for some opening remarks, and then we'll get started.
Timothy Power - Bristol-Myers Squibb Company - VP & Head of IR
Thanks very much, Akash, and thanks for the opportunity to be here this morning. I mean I suppose if I just take a step back, where we are right now. Clearly, the company is going through an important patent cycle at the moment, and the market is obviously focused on that understandably. I think that if we sort of put that in context, thinking about the fact that this isn't the first time Bristol has gone through a patent cycle.
And frankly, we've seen some other companies more recently go through something similar and come out very strong on the other side, I think it
Bristol-Myers Squibb Co at Jefferies London Healthcare Conference Transcript
Nov 16, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers